These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8701055)

  • 21. Visceral leishmaniasis in patients with AIDS: report of three cases treated with pentavalent antimony and interferon-gamma.
    de Górgolas M; Castrillo JM; Fernández Guerrero ML
    Clin Infect Dis; 1993 Jul; 17(1):56-58. PubMed ID: 8353246
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The evaluation of the tolerance and nephrotoxicity of pentavalent antimony administered in a dose of 40 mg Sb V/kg/day, 12/12 hr, for 30 days in the mucocutaneous form of leishmaniasis].
    Sampaio RN; de Paula CD; Sampaio JH; Furtado Rde S; Leal PP; Rosa TT; Rodrigues ME; Veiga JP
    Rev Soc Bras Med Trop; 1997; 30(6):457-63. PubMed ID: 9463192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic and parasitological evaluation of the bone marrow of dogs with visceral leishmaniasis submitted to multiple dose treatment with liposome-encapsulated meglumine antimoniate.
    Schettini DA; Costa Val AP; Souza LF; Demicheli C; Rocha OG; Melo MN; Michalick MS; Frézard F
    Braz J Med Biol Res; 2005 Dec; 38(12):1879-83. PubMed ID: 16302103
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low dosage combination of meglumine antimoniate plus allopurinol as first choice treatment of infantile visceral leishmaniasis in Italy.
    di Martino L; Mantovani MP; Gradoni L; Gramiccia M; Guandalini S
    Trans R Soc Trop Med Hyg; 1990; 84(4):534-5. PubMed ID: 2091347
    [No Abstract]   [Full Text] [Related]  

  • 25. [A 34-year-old man with lingual tumor. Lingual leishmaniasis in a patient with HIV infection].
    Sacristán O; Porcel JM; Panadés MJ; Rubio M
    Rev Clin Esp; 2001 Feb; 201(2):103-5. PubMed ID: 11345598
    [No Abstract]   [Full Text] [Related]  

  • 26. A double-blind randomized clinical trial of a topical herbal extract (Z-HE) vs. systemic meglumine antimoniate for the treatment of cutaneous leishmaniasis in Iran.
    Zerehsaz F; Salmanpour R; Handjani F; Ardehali S; Panjehshahin MR; Tabei SZ; Tabatabaee HR
    Int J Dermatol; 1999 Aug; 38(8):610-2. PubMed ID: 10487453
    [No Abstract]   [Full Text] [Related]  

  • 27. Failure of meglumine antimoniate to cure cutaneous lesions due to Leishmania major in Algeria.
    Belazzoug S; Neal RA
    Trans R Soc Trop Med Hyg; 1986; 80(4):670-1. PubMed ID: 3544363
    [No Abstract]   [Full Text] [Related]  

  • 28. A comparative study between the efficacy of systemic meglumine antimoniate therapy with standard or low dose plus oral omeprazole in the treatment of cutaneous leishmaniasis.
    Nilforoushzadeh MA; Jaffary F; Ansari N; Siadat AH; Nilforoushan Z; Firouz A
    J Vector Borne Dis; 2008 Dec; 45(4):287-91. PubMed ID: 19248655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrences of tegumentary leishmaniasis.
    Weigle KA; Valderrama L; Santrich C; Saravia NG
    Lancet; 1985 Sep; 2(8454):557-8. PubMed ID: 2863579
    [No Abstract]   [Full Text] [Related]  

  • 30. New delivery strategies for the old pentavalent antimonial drugs.
    Frézard F; Demicheli C
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1343-58. PubMed ID: 21029028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrocardiographic changes in patients with cutaneous leishmaniasis treated with systemic glucantime.
    Sadeghian G; Ziaei H; Sadeghi M
    Ann Acad Med Singap; 2008 Nov; 37(11):916-8. PubMed ID: 19082196
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness of intralesional meglumine antimoniate in the treatment of mucosal leishmaniasis of the Old World.
    Zaraa I; Karoui S; Osman AB
    J Dermatol; 2012 Feb; 39(2):201-3. PubMed ID: 21950659
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparison of meglumine antimoniate and pentamidine for peruvian cutaneous leishmaniasis.
    Andersen EM; Cruz-Saldarriaga M; Llanos-Cuentas A; Luz-Cjuno M; Echevarria J; Miranda-Verastegui C; Colina O; Berman JD
    Am J Trop Med Hyg; 2005 Feb; 72(2):133-7. PubMed ID: 15741547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intralesional treatment of cutaneous leishmaniasis: a report of two cases].
    Clarós P; Wienberg P; González MA; Clarós A; Clavería MA; López P
    Acta Otorrinolaringol Esp; 1996; 47(1):67-70. PubMed ID: 8645493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Acute pancreatitis with a fatal evolution due to antimonials in patients with visceral leishmaniasis and HIV infection].
    Santos J; Rivero A; Márquez M
    An Med Interna; 2000 Oct; 17(10):562-3. PubMed ID: 11109659
    [No Abstract]   [Full Text] [Related]  

  • 36. Glucantime-resistant visceral leishmaniasis in immunocompromised patients.
    Verdejo J; Alvar J; Polo RM; González-Lahoz JM
    Am J Med; 1988 Jul; 85(1):128. PubMed ID: 3389377
    [No Abstract]   [Full Text] [Related]  

  • 37. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients.
    Delgado J; Macías J; Pineda JA; Corzo JE; González-Moreno MP; de la Rosa R; Sánchez-Quijano A; Leal M; Lissen E
    Am J Trop Med Hyg; 1999 Nov; 61(5):766-9. PubMed ID: 10586909
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of cutaneous leishmaniasis with either topical paromomycin or intralesional meglumine antimoniate.
    Faghihi G; Tavakoli-kia R
    Clin Exp Dermatol; 2003 Jan; 28(1):13-6. PubMed ID: 12558620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combination therapy with liposomal amphotericin b (ambisome), n-methylglucamine antimoniate (glucantime), and pentamidine isethionate in a refractory visceral leishmaniasis case.
    Gomes MAF; Medeiros LLC; Lobo FPD; Wanderley NRS; Matos APR; Jácome TDN; Monteiro MGL; Luz KG
    Rev Soc Bras Med Trop; 2018; 51(3):393-396. PubMed ID: 29972577
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follicular mucinosis associated with cutaneous leishmaniasis.
    Abajo P; Martín R; Daudén E
    Acta Derm Venereol; 1998 Jul; 78(4):315. PubMed ID: 9689315
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.